A detailed history of South State Corp transactions in Dexcom Inc stock. As of the latest transaction made, South State Corp holds 278 shares of DXCM stock, worth $23,763. This represents 0.0% of its overall portfolio holdings.

Number of Shares
278
Previous 128 117.19%
Holding current value
$23,763
Previous $9,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

BUY
$67.74 - $90.75 $10,161 - $13,612
150 Added 117.19%
278 $18,000
Q4 2024

Feb 10, 2025

BUY
$65.68 - $81.01 $6,633 - $8,182
101 Added 374.07%
128 $9,000
Q2 2024

Aug 02, 2024

SELL
$110.31 - $140.45 $62,214 - $79,213
-564 Reduced 95.43%
27 $3,000
Q1 2024

May 06, 2024

BUY
$114.22 - $140.1 $67,504 - $82,799
591 New
591 $81,000
Q3 2023

Nov 07, 2023

BUY
$86.06 - $137.93 $1,290 - $2,068
15 New
15 $1,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $33B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track South State Corp Portfolio

Follow South State Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

News

Stay updated on South State Corp with notifications on news.